Novel vaccines have been created to prevent co-infections of HIV and the Hepatitis C virus (HCV), a growing health problem in Europe.
The vaccines, developed by scientists working on the ground breaking PEACHI project, combine antiretroviral therapies and vaccines that stimulate targeted immune responses. The HCV virus, which can lead to chronic liver disease and cancer, is a leading cause of death in HIV co-infected individuals. An estimated 2.3 million people globally are co-infected with HIV and HCV.
The EU-funded PEACHI project sought to address this challenge by building upon the success of antiretroviral therapies, which have led to a dramatic improvement in life expectancy for people with HIV infection. While the drugs do not kill or cure the virus, they can prevent the growth of the virus when taken in combination. When the virus is slowed down, the danger of further HIV complications is reduced.
Read more: cordis.europa.eu
EURAXESS - Researchers in Motion is a unique pan-European initiative providing access to a complete range of information and support services to researchers wishing to pursue their research careers in Europe or stay connected to it
Συμπληρώστε το e-mail σας και θα λαμβάνετε περιοδικά το Δελτίο Τύπου της Ραδιοφωνικής Εκπομπής "Διασυνδεθείτε".
Παρακαλώ, όσοι διαθέτετε λογαριασμό e-mail του Δ.Π.Θ μην τον χρησιμοποιείτε για την εγγραφή σας στο newsletter της Δομής Απασχόλησης & Σταδιοδρομίας του Δ.Π.Θ.
